Entities / Company
BioNano Genomics.
company in San Diego, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 29
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
BioNano Genomics presented OGM applications at the European Cytogenomics Association conference.Some support1 report
-
BioNano Genomics released updated Solve software on August 5, 2025, which analyzes next-generation sequencing (NGS) data.Some support1 report
-
BioNano Genomics CEO presented at the H.C. Wainwright 27th Annual Global Investment Conference.Some support4 reports
-
Via software was accepted as the gold standard for CNV analysis.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around BioNano Genomics this week
News at the entities that move BioNano Genomics most-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves BioNano Genomics
-
Bio-Techne OperationalBio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.Moves BioNano Genomics
Connections
The 2 strongest of 29, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
BioNano Genomics is a publicly listed company trading on the Nasdaq stock exchange.
-
Bio-Techne Operational
Bio-Techne and BioNano Genomics are actively competing within the life science and biotech market.
History
Events by the month they beganJune 2026
4 events- BioNano Genomics presented OGM applications at the European Cytogenomics Association conference.
- BioNano Genomics released updated Solve software on August 5, 2025, which analyzes next-generation sequencing (NGS) data.
- BioNano Genomics CEO presented at the H.C. Wainwright 27th Annual Global Investment Conference.
- Via software was accepted as the gold standard for CNV analysis.